CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment.
Volpin V, Michels T, Sorrentino A, Menevse AN, Knoll G, Ditz M, Milenkovic VM, Chen CY, Rathinasamy A, Griewank K, Boutros M, Haferkamp S, Berneburg M, Wetzel CH, Seckinger A, Hose D, Goldschmidt H, Ehrenschwender M, Witzens-Harig M, Szoor A, Vereb G, Khandelwal N, Beckhove P.
Volpin V, et al. Among authors: szoor a.
Cancer Immunol Res. 2020 Sep;8(9):1163-1179. doi: 10.1158/2326-6066.CIR-19-0608. Epub 2020 Jul 14.
Cancer Immunol Res. 2020.
PMID: 32665263